Frames and frame selection

There is an element of physics when it comes to matching a frame to the patient’s head, with the forces of weight and friction playing a big part in overall comfort and fit, writes LEIGH ROBINSON. Read more

Latanoprost – a lasting glaucoma breakthrough

Latanoprost was a game-changing glaucoma therapy and still remains a go-to treatment for many ophthalmologists more than two decades later. PROFESSOR JOHN GRIGG – an investigator on an important clinical trial for the drug in 1996 – traces its history and explains how it fits into the treatment algorithm today.

Read more

Standing up for dry eye patients

As a veteran dry eye patient, I have experienced many highs and lows. From feeling temporary relief via expert treatment through to complex psychological trauma from debilitating symptoms.

Read more

Elective surgery post-COVID

An elective surgery shutdown as part of the COVID-19 response wreaked havoc on an already-stretched hospital system last year. Insight checks in on how each state is faring one year on. Read more

Vertex distance, every millimetre counts

High-powered lenses still require the back vertex distance to be measured otherwise the wearer may not get the best out of their lenses. Steven Daras dissects this underused dispensing measurement. Read more

Streamlining the optometric Medicare schedule

With optometrists performing three-quarters of all eye exams in Australia, the optometric Medicare schedule has a major bearing on the quality of eye health in this country. Insight dives into the MBS Taskforce’s endorsed report that could reshape primary eyecare for decades to come.

Read more

The world of neuro-ophthalmology

Neuro-ophthalmology (N/O) is an interesting subspecialty because it crosses boundaries. Almost exclusively a ‘medical–type’ specialty rather than ‘surgical’, about half of its practitioners in Australia and New Zealand are neurologists and the other half are ophthalmologists.

Read more